The analysis revealed FCGBP expression to be higher in 14 tumors, including BRCA, CHOL, COAD, ESCA, GBM, AML, LGG, LIHC, LUAD, OV, PAAD, STAD, TGCT, and UCS. Here, FCGBP is linked to acute myeloid leukemia.